Diagnostic and therapeutic technology assessment. Immunoaugmentative therapy
The scientific evidence to date, as well as the history of IAT, will allow
no other conclusion than that IAT is unequivocally dangerous to its
patients and of no proved value as a treatment for cancer. Physicians who
know of patients receiving IAT must be aware of the high risk those people
are incurring for life-threatening infections of several types.
